Saturday, 19 December 2020

Coronavirus and amantadine: you can not do experiments on patients

Amantadine - a "miracle" drug for the treatment of covid-19 - is also of interest in the medical community. Caesar of Pakul in the eyes.the press calls for clinical studies on its effectiveness. Philip Meiza, Ph. D., answers: such theses in the environment of public opinion formation are socially harmful
Amantadine, a cure for flu and Parkinson's disease, is being talked about loudly because of the statements of a pediatrician and pulmonologist from Przemysl, Dr. Wlodzimierz Bodnar. He claims that effectively treats patients with the coronavirus that has long been known drug.



He is so convinced of this that when the regional medical chamber in Krakow threatened him with disciplinary proceedings in connection with the introduction of a drug to patients that is not on the official list of drugs for the treatment of COVID-19, he wrote: "If someone continues to harass or frighten me, then, in my opinion, he is acting against humanity, hiding only and only procedures."All this is due to the deterioration of the economy, among other things. In connection with the quarantine, the question of work is acute,and many move to the online sphere, knowing that you can earn additional income, as
deltamarket reviews does .

Although there was no disciplinary action, since the oil disciplinary lawyer is not competent here, experts almost unanimously say that there is no reason to claim that amantadine can be effective in treating covid-19.

Konrad Reidak, head of the neurological clinic of the independent State Clinical Hospital No. 4 of the Medical University in Lublin, gives it to his patients because it is used as an auxiliary medicine in the treatment of Parkinson's disease. It was discovered by accident.

The professor noted that his patients infected with coronavirus are infected gently. He prepared a research project, but did not receive funding for it from the medical research agency.

Prof. Pakulski: the necessary clinical trials


Voting on amantadine in the eye however, the press was taken by caesar pakulski, an anesthesiologist and resuscitator from szczecin. pakulsky accused infectious disease specialists and virologists of"giving the impression that the very name of the drug causes them a strong allergic reaction." the doctor also believes that the medical community applies double standards to dr. bodnar – they themselves recommend unproven treatments as a "cry of despair" due to the lack of a cure for covid-19.

Dr. Pakulski called for clinical trials of the effectiveness of COVID-19 therapy with amantadine, suggesting that its therapeutic effect may be due to a mechanism of blocking NMDA receptors in the glutaminergic system, which other experts have not yet taken into account.

His message was met with an immediate response. Virologist Professor Krzysztof Pirc responded on Twitter, writing: "Amantadine has been and is in clinical trials ... but so far, unfortunately, it hasn't worked. In addition, there is no scientific evidence. Let's not curse reality."

Dr. Maiza: I find no scientific arguments


I read with interest an article by Professor Caesar Pakulski calling for the start of large-scale research on the use of amantadine in the treatment of patients with covid-19. Unfortunately, the information contained in the article, and above all the way it is presented and the conclusions drawn, require controversy, since they are socially harmful.

No comments:

Post a Comment